Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Hepatic Artery Chemotherapy in Localized Pancreatic Cancer
NCT05634720Phase 4Active, not recruiting
- Sponsor
- Duke University
- Start
- Jan 2024
- Primary completion
- Nov 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of floxuridine, oxaliplatin in pancreatic ductal adenocarcinoma (PDAC), sponsored by Duke University. Started Jan 2024; status: active, not recruiting.
02
Drugs
floxuridineoxaliplatin
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT05634720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05634720.